Print

Mucovac2

Mucovac2: A Phase I clinical trial to assess the safety and immunogenicity of three HIV CN54gp140 immunisations administered through the intramuscular, intranasal and intravaginal routes in healthy female volunteers

Trial Details:

I Completed
St George's University London, Imperial College, Hull York Medical School (HYMS; University of York), the Medical Research Council Clinical Trial Unit and the Infectious Disease Research Institute (IDRI) November 01, 2011
CN54gp140 Env C
CN54gp140 Protein
United Kingdom 36